Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
771.12 | -48,81% | -27,8% | 694.320,6 | 0,66% | 2,63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
912.90 | -2,1% | 18,21% | 4.066.820,23 | 1,02% | 18,5% |
|
ENXTBR:ARGX
argenx
|
344.90 | 0% | 0% | 20.488,36 | 0% | 0% |
|
CPSE:GMAB
Genmab A/S
|
2026.00 | 62,89% | 121,79% | 133.380,66 | 0% | 22,71% |
|
NasdaqGS:PODD
Insulet
|
185.38 | 705,17% | 997,4% | 12.431,09 | 0% | 122,88% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
50.80 | 18,28% | 30,99% | 10.363,08 | 2,32% | 10,99% |
|
LSE:HIK
Hikma Pharmaceuticals PLC
|
19.83 | 25,31% | 38,17% | 4.424,39 | 2,8% | 10,04% |
|
HLSE:ORNBV
Orion Oyj
|
37.71 | 22,61% | 65,62% | 5.117,58 | 4,31% | -0,43% |
|
CPSE:ALK B
ALK-Abelló A/S
|
155.90 | 48,16% | 94,21% | 33.908,31 | 0% | 171,44% |
|
XTRA:MOR
MorphoSys
|
69.05 | 0% | 0% | 2.523,4 | 0% | 0% |
|
LSE:INDV
Indivior PLC
|
13.52 | -23,61% | -1,68% | 1.952,43 | 0% | -2,7% |
|
BME:ALM
Almirall
|
9.51 | -45,22% | 27,15% | 1.944,22 | 2,03% | -30,96% |
|
NasdaqGS:AMPH
Amphastar Pharmaceuticals
|
42.74 | 226,92% | 260,8% | 2.085,6 | 0% | 73,69% |
|
XTRA:EVT
Evotec
|
10.27 | -32,05% | 101,29% | 1.726,81 | 0% | 0% |
|
SWX:COPN
Cosmo Pharmaceuticals N.V.
|
73.50 | -8,78% | 50,69% | 1.136,54 | 2,67% | -76,88% |
|
BME:FAE
Faes Farma
|
3.60 | 14,51% | 24,13% | 1.089,37 | 4,25% | 6,96% |
|
BME:PHM
Pharma Mar
|
36.24 | 0% | 0% | 536,95 | 1,81% | -39,63% |
|
SWX:BSLN
Basilea Pharmaceutica
|
44.30 | -24,32% | -26,01% | 529,94 | 0% | -15,69% |
|
NasdaqGS:XERS
Xeris Biopharma Holdings
|
2.02 | 0% | 0% | 260,93 | 0% | 0% |
|
ENXTPA:DBV
DBV Technologies
|
1.30 | 0% | 0% | 115,65 | 0% | 0% |
